BRCA2 germline mutations in Japanese breast cancer families

International Journal of Cancer

Volumn 74, Issue 2, 1997, Pages 199-204

  Inoue, Rie ^a   Ushijima, Toshikazu ^b   Fukutomi, Takashi ^c   Fukami, Atsuo ^d   Sugimura, Haruhiko ^e   Inoue, Shingo ^a   Okonogi, Hideo ^b   Sugimura, Takashi ^b   Matsumoto, Yoshiro ^a   Nagao, Minako ^b  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d Kameda General Hospital   (Japan)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRCA2; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; JAPAN; ONCOGENE; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; BASE SEQUENCE; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; GENES, TUMOR SUPPRESSOR; GERM-LINE MUTATION; HUMANS; JAPAN; MALE; MOLECULAR SEQUENCE DATA; PEDIGREE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 0030922116     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970422)74:2<199::AID-IJC11>3.0.CO;2-9     Document Type: Article

References (12)

1. BERMAN, D.B., COSTALAS, J., SCHULTZ, D.C., GRANA, G., DALY, M. and GODWIN, A.K., A common mutation in BRCA2 that predisposes to variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals. Cancer Res., 56, 3409-3414 (1996).
2. COUCH, F.J. and 19 OTHERS, BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nature (Genet.), 13, 123-125 (1996).
3. INOUE, R., FUKUTOMI, T., USHIJIMA, T., MATSUMOTO, Y., SUGIMURA, T. and NAGAO, M., Germline mutation of BRCA1 in Japanese breast cancer families. Cancer Res., 55, 3521-3524 (1995).
4. MIKI, Y. and 44 OTHERS, A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71 (1994).
5. NEUHAUSEN, S. and 13 OTHERS, Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nature (Genet.), 13, 126-128 (1996).
6. PHELAN, C.M. and 20 OTHERS, Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nature (Genet.), 13, 120-122 (1996).
7. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Isolation of high-molecular-weight DNA from mammalian cells, pp. 9.14-9.23. Cold Spring Harbor Laboratory Press, New York (1989).
8. TAVTIGIAN, S.V. and 50 OTHERS, The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds [see comments]. Nature (Genet.), 12, 333-337 (1996).
9. TENG, D.H.-F. and 17 OTHERS, Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nature (Genet.), 13, 241-244 (1996).
10. THORLACIUS, S., OLAFSDOTTIR, G., TRYGGVADOTTIR, L., NEUHAUSEN, S., JONASSON, J.G., TAVIGIAN, S.V., TULINIUS, H., OGMUNDSDOTTIR, H.M. and EYFJORD, J.E., A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nature (Genet.), 13, 117-119 (1996).
11. WOOSTER, R. and 40 OTHERS, Identification of the breast cancer susceptibility gene BRCA2 [see comments]. Nature (Lond.), 378, 789-792 (1995).
12. WOOSTER, R. and 30 OTHERS, Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science, 265, 2088-2090 (1994).